Fubon Life Insurance related stories
All articles and analysis
Fubon Life backs Thoma Bravo fund with $70m commitmentThe Taiwan-based insurance company has backed a buyout fund.
Side Letter: Pluralsight's PE/PD implicationsThe high-profile Pluralsight restructuring highlights the changing relationship between private equity sponsor and private credit manager. Plus: the Australian regulator appears to be taking a leaf out of the SEC's book. Here's today's brief, for our valued subscribers only.
Side Letter: Carry tax clarityWhat constitutes capital at risk when it comes to CGT treatment of carry? Plus: Why sector specialists might survive PE's consolidation craze and HarbourVest raises a secondaries giant. Here's today's brief, for our valued subscribers only.
Fubon Life backs Blue Owl GP stakes fund with $70m commitmentThe Taiwan-based insurance company has backed a GP stakes fund.
Fubon Life backs Clearlake fund with $70m commitmentThe Taiwan-based insurance company has backed a private equity fund.
Side Letter: HKVCA takeawaysDispatches from the Hong Kong Venture Capital & Private Equity Association's Greater China Private Equity Summit this morning. Plus: Thailand's pension giant is pushing further into PE. Here's today's brief, for our valued subscribers only.
Fubon Life backs Veritas fund with $70m commitmentTaiwan-based insurance company backs a private equity fund that focuses on North American buyouts.
Side Letter: Partners Group's royaltiesPartners Group has launched a new strategy dedicated to private markets royalties. Plus: an exploration of sponsor-led PIPEs; and another Japan fund has reached a close. Here's today's brief, for our valued subscribers only.
Taiwan’s insurance giants dial back on private equityThe country’s life insurers have offloaded fund stakes and halved their annual commitments partly due to current and impending capital requirements.
PEI Awards 2023: Secondaries winnersThe top secondaries deals, firms, law firms and advisers of the year.